Author： Jeon Eunjin Chung Kyung-Sook An Hyo-Jin
Publisher： NRC Research Press
E-ISSN： 1205-7541|94|1|104-111
ISSN： 1205-7541
Source： Canadian Journal of Physiology and Pharmacology, Vol.94, Iss.1, 2016-01, pp. : 104-111
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Treatment options for benign prostatic hyperplasia
By Thurlow R.J.
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Dutasteride for the treatment of benign prostatic hyperplasia
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. :
Dutasteride/Tamsulosin: In Benign Prostatic Hyperplasia
Drugs & Aging, Vol. 29, Iss. 5, 2012-05 ,pp. :
The mechanism of epristeride against benign prostatic hyperplasia
By Sun Z.-Y. Wu H.-Y. Wang M.-Y. Tu Z.-H.
European Journal of Pharmacology, Vol. 371, Iss. 2, 1999-04 ,pp. :